Skip to content

Assembly Biosciences ASMB Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$9.08M-$9.2M+9.8%-$10.2M-15.6%-$8.82M+14.7%
$26K-18.8%$32K0.0%$32K0.0%$32K-3.0%$33K+3.1%
$1.12M-23.6%$1.46M-12.5%$1.67M+100%$834K+17.1%$712K-5.2%
-$22.1M-$15.13M+9.7%-$16.76M+28.5%-$23.44M-5,659%
$19K-20.8%$24K-42.9%$42K$0$0
-$5.38M-$158.27M-1,031%$16.99M+158%$6.59M
$149K-67.3%$456K-99.7%$171.93M+48,060%$357K-81.4%$1.92M-88.7%
-$27.33M-176%$35.92M+2,540%-$1.47M-348%$593K+104%-$14.93M-251%
-$22.12M-$15.18M+9.4%-$16.76M+28.5%-$23.44M-5,659%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Assembly Biosciences generate?
Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
What is Assembly Biosciences's free cash flow?
After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
Where does Assembly Biosciences's cash flow data come from?
Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.